Surgery versus chemotherapy for early-stage small cell esophageal cancer
Part of Cancer, Digestive system clinical trials.
This study compares how well surgery works compared to chemotherapy and radiation for treating small cell cancer that started in the esophagus and hasn't spread far. Researchers will examine which approach helps patients live longer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with small cell cancer that originated in your esophagus (confirmed by biopsy)
- Your cancer is limited-stage, meaning it is confined to the esophagus and nearby lymph nodes with no spread to distant organs
- You received definitive treatment (either surgery, or chemotherapy combined with radiation) at the study hospital
- You are 18 years or older
- Your medical records include complete information about your diagnosis, treatment, and follow-up care
- You do not have any other active cancer diagnoses from the past 5 years
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving chemotherapy combined with immunotherapy before surgery works better than the standard chemoradiation for esophageal cancer that can be removed. It may help reduce tumor size and improve outcomes.
This trial tests whether adding the immunotherapy drug serplulimab to standard chemotherapy before surgery can help people with limited-stage small cell carcinoma of the esophagus. It aims to see if this combination shrinks tumors and improves outcomes.
This study compares two ways to treat cervical esophagus squamous cell cancer: surgery alone versus chemo-radiation (chemotherapy plus radiation). It may help find the best approach to control the cancer while keeping side effects manageable.
This trial studies whether adding chemotherapy after surgery for esophageal squamous cell cancer can reduce the chance the cancer returns. It focuses on people whose surgery removed cancerous lymph nodes and who are healthy enough to tolerate chemotherapy.
This trial tests a combination of the immunotherapy drug adebrelimab with standard chemotherapy and radiation for people with a rare type of esophageal cancer called small cell carcinoma. The goal is to see if this approach can help shrink or control the tumor.
This study compares two treatment approaches for certain locally advanced esophageal cancers: chemoradiation (chemo plus radiation) versus esophagus surgery. It may help find which option works better to control the cancer and improve outcomes.
Hear when a new Esophageal Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.